Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Short term Debt (2021 - 2025)

Historic Short term Debt for Journey Medical (DERM) over the last 4 years, with Q3 2025 value amounting to $5.6 million.

  • Journey Medical's Short term Debt changed N/A to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2022, which is 26305.42% up from last year.
  • As of Q3 2025, Journey Medical's Short term Debt stood at $5.6 million.
  • Journey Medical's 5-year Short term Debt high stood at $9.9 million for Q2 2023, and its period low was $812000.0 during Q4 2021.
  • For the 4-year period, Journey Medical's Short term Debt averaged around $5.0 million, with its median value being $3.8 million (2025).
  • Over the last 5 years, Journey Medical's Short term Debt had its largest YoY gain of 26305.42% in 2022, and its largest YoY loss of 26305.42% in 2022.
  • Over the past 4 years, Journey Medical's Short term Debt (Quarter) stood at $812000.0 in 2021, then skyrocketed by 263.05% to $2.9 million in 2022, then soared by 237.25% to $9.9 million in 2023, then crashed by 43.42% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q3 2025, $3.8 million for Q2 2025, and $1.9 million during Q1 2025.